Infectious complications in hiv patients and large b cell lymphoma at the instituto nacional de cancerologÿa, mexico
BACKGROUND: The Diffuse Large B Cell Lymphoma (DLBCL) is the most common Non Hodgkin Lymphoma. The frequency and type of infections in patients with DLBCL and HIV, and the impact on the survival are still unknown. METHODS: We performed an observational, retrospective, longitudinal study in patients...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-09-01
|
Series: | Hematology Reports |
Online Access: | https://www.pagepress.org/journals/index.php/hr/article/view/8925 |
_version_ | 1797935622291193856 |
---|---|
author | V. Bravo Villa A. Martin A.F. Ramírez |
author_facet | V. Bravo Villa A. Martin A.F. Ramírez |
author_sort | V. Bravo Villa |
collection | DOAJ |
description | BACKGROUND: The Diffuse Large B Cell Lymphoma (DLBCL) is the most common Non Hodgkin Lymphoma. The frequency and type of infections in patients with DLBCL and HIV, and the impact on the survival are still unknown. METHODS: We performed an observational, retrospective, longitudinal study in patients with DLBCL with and without HIV, that receive chemotherapy treatment from 2010-2019 at the Instituto Nacional de Cancerología, México. RESULTS: We analyzed 170 patients; 56 patients with HIV and 114 without HIV. We observed a predominance of male gender and advanced stage in both groups. During the first year of chemotherapy, 46% of patients without HIV and 70% with HIV, had an infectious complication. (p=0.0001). Gram-negative Enterobacteria predominated, with a pattern of sensibility pan sensible. In the bivariate analyses, hypoalbuminemia, high ECOG score, EPOCH chemotherapy and HIV positivity status were associated with the presence of infections. One episode of infection was associated with a decrease in Event free survival (EFS) (RR 2.14, p=0.007) and Overall Survival (OS) (RR 2.5, p=0.001), independently of the HIV status. In the multivariate analysis for OS, infections at diagnosis and Central Nervous System (CNS) infiltration were independent prognostic factors for survival. DISCUSSION: Patients with HIV infection and lymphoma have higher number of infections than patients without HIV, however HIV positivity status does not impact the survival of these patients. The functional and nutritional deterioration were associated with the development of infections in the entire cohort. Infections had an impact on EFS and OS, regardless of HIV status. |
first_indexed | 2024-04-10T18:18:01Z |
format | Article |
id | doaj.art-75d9cfeeed1d43a495d8380f4258c67e |
institution | Directory Open Access Journal |
issn | 2038-8322 2038-8330 |
language | English |
last_indexed | 2024-04-10T18:18:01Z |
publishDate | 2020-09-01 |
publisher | MDPI AG |
record_format | Article |
series | Hematology Reports |
spelling | doaj.art-75d9cfeeed1d43a495d8380f4258c67e2023-02-02T08:09:03ZengMDPI AGHematology Reports2038-83222038-83302020-09-0112s1Infectious complications in hiv patients and large b cell lymphoma at the instituto nacional de cancerologÿa, mexicoV. Bravo Villa0A. Martin1A.F. Ramírez2Instituto Nacional de CancerologíaInstituto Nacional de CancerologíaInstituto Nacional de CancerologíaBACKGROUND: The Diffuse Large B Cell Lymphoma (DLBCL) is the most common Non Hodgkin Lymphoma. The frequency and type of infections in patients with DLBCL and HIV, and the impact on the survival are still unknown. METHODS: We performed an observational, retrospective, longitudinal study in patients with DLBCL with and without HIV, that receive chemotherapy treatment from 2010-2019 at the Instituto Nacional de Cancerología, México. RESULTS: We analyzed 170 patients; 56 patients with HIV and 114 without HIV. We observed a predominance of male gender and advanced stage in both groups. During the first year of chemotherapy, 46% of patients without HIV and 70% with HIV, had an infectious complication. (p=0.0001). Gram-negative Enterobacteria predominated, with a pattern of sensibility pan sensible. In the bivariate analyses, hypoalbuminemia, high ECOG score, EPOCH chemotherapy and HIV positivity status were associated with the presence of infections. One episode of infection was associated with a decrease in Event free survival (EFS) (RR 2.14, p=0.007) and Overall Survival (OS) (RR 2.5, p=0.001), independently of the HIV status. In the multivariate analysis for OS, infections at diagnosis and Central Nervous System (CNS) infiltration were independent prognostic factors for survival. DISCUSSION: Patients with HIV infection and lymphoma have higher number of infections than patients without HIV, however HIV positivity status does not impact the survival of these patients. The functional and nutritional deterioration were associated with the development of infections in the entire cohort. Infections had an impact on EFS and OS, regardless of HIV status.https://www.pagepress.org/journals/index.php/hr/article/view/8925 |
spellingShingle | V. Bravo Villa A. Martin A.F. Ramírez Infectious complications in hiv patients and large b cell lymphoma at the instituto nacional de cancerologÿa, mexico Hematology Reports |
title | Infectious complications in hiv patients and large b cell lymphoma at the instituto nacional de cancerologÿa, mexico |
title_full | Infectious complications in hiv patients and large b cell lymphoma at the instituto nacional de cancerologÿa, mexico |
title_fullStr | Infectious complications in hiv patients and large b cell lymphoma at the instituto nacional de cancerologÿa, mexico |
title_full_unstemmed | Infectious complications in hiv patients and large b cell lymphoma at the instituto nacional de cancerologÿa, mexico |
title_short | Infectious complications in hiv patients and large b cell lymphoma at the instituto nacional de cancerologÿa, mexico |
title_sort | infectious complications in hiv patients and large b cell lymphoma at the instituto nacional de cancerologya mexico |
url | https://www.pagepress.org/journals/index.php/hr/article/view/8925 |
work_keys_str_mv | AT vbravovilla infectiouscomplicationsinhivpatientsandlargebcelllymphomaattheinstitutonacionaldecancerologyamexico AT amartin infectiouscomplicationsinhivpatientsandlargebcelllymphomaattheinstitutonacionaldecancerologyamexico AT aframirez infectiouscomplicationsinhivpatientsandlargebcelllymphomaattheinstitutonacionaldecancerologyamexico |